Fosun International: Total Revenue in 2025 Reaches RMB173.43 Billion, with Overseas Revenue Accounting for 54.7%, Aiming to Achieve"RMB10 Billion in Profit"
Fosun International (OTC:FOSUF) reported total 2025 revenue of RMB173.43 billion and adjusted industrial operation profit of RMB4 billion.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Fosun International (OTC:FOSUF) reported total 2025 revenue of RMB173.43 billion and adjusted industrial operation profit of RMB4 billion. Overseas revenue was RMB94.86 billion (54.7%). The Group recorded a RMB23.4 billion book loss from impairments and revaluations.
Fosun invested RMB7.8 billion in technology innovation, secured multiple drug approvals and clinical starts, held RMB61.1 billion cash, and set medium-term targets including restoring annual profit to ~RMB10 billion.
Positive
- Total revenue of RMB173.43 billion in 2025
- Overseas revenue RMB94.86 billion (54.7% of total)
- Adjusted industrial operation profit of RMB4 billion
- Fosun Pharma net profit RMB3.371 billion (+21.69% YoY)
- Tech investment RMB7.8 billion and 16 indications approved
Negative
- Book loss from impairments and revaluations RMB23.4 billion
- Real estate-related impairment ~55% of total impairments
- Total debt to total capital ratio at 57%
Key Figures
- Total revenue
- RMB173.43 billion
- 12 months ended 31 Dec 2025
- Adj. industrial operation profit
- RMB4 billion
- 12 months ended 31 Dec 2025
- Overseas revenue
- RMB94.86 billion (54.7%)
- 12 months ended 31 Dec 2025; +5.4 ppt YoY share
- Annual book loss
- RMB23.4 billion
- Non-cash impairments and revaluations in 2025
- Total debt to capital
- 57%
- As at end of Reporting Period
- Cash and term deposits
- RMB61.1 billion
- As at end of Reporting Period
- Unutilized banking facilities
- RMB144.6 billion
- As at end of Reporting Period
- Expected 2026 dividends
- ≥HKD1.5 billion
- Dividends for 2026 financial year
Historical Context
-
Multiple ESG awards and global healthcare innovation highlights.
-
Named an ESG Leading Enterprise with multiple high ESG ratings.
-
Gold Award and Best Sustainability Team for ESG performance.
-
CIIE participation highlighting oncology and CAR-T innovations.
-
Launch of International Jewelry Fashion Theme Month in Shanghai.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
non-cash impairment financial
goodwill financial
intangible assets financial
dividend payout ratio financial
credit rating financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
During the Reporting Period, the Group's total revenue reached
During the Reporting Period, the Group's investment in technology innovation reached
During the Reporting Period, the Group's overseas revenue reached
Fosun has continued to advance its strategy of "streamlining operations and strengthening the business, focusing on core businesses". During the Reporting Period, pursuant to the principle of prudence, Fosun made non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators and goodwill and intangible assets of certain non-core business segments, resulting in a book loss of
In his letter to shareholders, Guo Guangchang, Chairman of Fosun International, stated: "Some of the projects we invested in years ago are now indeed valued differently under current market conditions from what we expected at the time of investment. Accordingly, the Board has prudently chosen to complete this asset impairment, allowing Fosun to better concentrate its resources and efforts on high-growth core sectors. As the global economy presents opportunities amid fluctuations and
At the same time, Fosun has maintained a healthy financial position, with ample cash reserves, a solid net asset base, and positive net cash inflow from operating activities. As at the end of the Reporting Period, total debt to total capital ratio was
"It is precisely this strong foundation, together with the continued support of our partners, that gives us the confidence and determination to 'repair the roof while the sun is shining' — to shed burdens at this stage and pursue predictable, sustainable growth for the future. We must strengthen our core businesses with greater focus and depth. This is the path for Fosun to move more steadily and go further in the next phase," said Guo Guangchang.
Fosun also announced its medium-term financial targets: to strive to gradually restore annual profit to around
In terms of further enhancing shareholder returns, in addition to share purchases by the controlling shareholder and management, as well as the Company's continued share buybacks, Fosun announced that it plans to increase its target dividend payout ratio for the 2026 financial year from the current
"For the future, Fosun will not pursue short-term gains; instead, we will build a solid foundation for enduring growth," said Guo Guangchang.
SOURCE Fosun
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.